HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Reticular dysgenesis in a preterm infant: a case report.

Abstract
Reticular dysgenesis (RD) is a rare congenital immunodeficiency classified within the severe combined immunodeficiencies (SCIDs) and characterized by impairment of both lymphoid and myeloid cell development. Neutropenia unresponsive to recombinant human granulocyte colony-stimulating factor (rGCSF) is the hallmark of RD and the clinical course is rapidly fatal due to overwhelming infections. The authors report a female newborn at 32 weeks of gestation presenting with severe leukopenia at birth. The bone marrow showed a maturation arrest in the myeloid and lymphoid lineage. She had no response to granulocyte colony stimulating factor (rGCSF) treatment and died with sepsis at age of 2 months.
AuthorsHese Cosar, Zelal Kahramaner, Aydin Erdemir, Ali Kanik, Ebru Turkoglu, Sumer Sutcuoglu, Can Ozturk, Berna Atabay, Esra Arun Ozer
JournalPediatric hematology and oncology (Pediatr Hematol Oncol) Vol. 27 Issue 8 Pg. 646-9 (Nov 2010) ISSN: 1521-0669 [Electronic] England
PMID20863163 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Granulocyte Colony-Stimulating Factor
Topics
  • Bone Marrow Transplantation
  • Fatal Outcome
  • Female
  • Granulocyte Colony-Stimulating Factor (therapeutic use)
  • Humans
  • Infant
  • Leukopenia (diagnosis, therapy)
  • Severe Combined Immunodeficiency (diagnosis, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: